Michael Naarendorp Med Doctor - 10026 New York City, NY

Business Name: Michael Naarendorp Med Doctor
Categorized In: Doctors
Address: 51 Saint Nicholas Avenue Apartment 1, New York City, NY 10026
Phone Number: (212) 360-5752
NAICS Code: 6211110
SIC Code: 8011
Business Type: B2C (Business to Consumer)
Employee #: 1 to 4
Location Type: Single Location
Annual Revenue ($): $1.000.000 to $2.499.999
Share This Business:
Similar Businesses: J Valld Ltd - New York City, NY 10026
Dayson Don A MD - New York City, NY 10026
Kenneth D Kirshbaum Md - New York City, NY 10026
Damico Richard J DO - New York City, NY 10026
Elliott Fitzroy MD - New York City, NY 10026
Jaff Stacey MD - New York City, NY 10026
Boccardo Daniel A MD - New York City, NY 10026
Dove Arthur MD - New York City, NY 10026
Mack Theresa A MD - New York City, NY 10026
Naarendorp Michael MD - New York City, NY 10026
Mc Lean-Long Carol A MD - New York City, NY 10026
Melamed Samuel MD - New York City, NY 10026
Granderson Joseph D MD - New York City, NY 10026
Stern Margaret E MD - New York City, NY 10026
Grossmark Robert MD - New York City, NY 10026
Nailor John R MD - New York City, NY 10026
Lambert Nahesi N MD - New York City, NY 10026
Berliner Neil E MD - New York City, NY 10026
Pimentel Pablo MD - New York City, NY 10026
Wright Lewis Z MD - New York City, NY 10026

Michael Naarendorp Med Doctor provides professional Doctors from its single location at the coordinates 40.800263,-73.952552.

The company offers B2C variables under the SIC code 8011 and NAICS code 6211110, while making an annual revenue of $1.000.000 to $2.499.999 and hiring a total of 1 to 4 employees.

Founded in 0, the company can now be visited at 51 Saint Nicholas Avenue Apartment 1, New York City, New York 10026 or contacted through representative at (212) 360-5752.

For frequently asked questions and further inquiries about professional Doctors, get to know more about Michael Naarendorp Med Doctor through its company website at . Engage with this business on its social media platforms through on Twitter and on Facebook.